ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
7,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
9,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
10,1,Headache,Headaches NEC,Headaches,Nerv,N
10,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
12,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
12,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
14,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
14,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
14,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
15,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
16,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
16,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
18,1,Blood test,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
18,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
18,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
19,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
19,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
20,1,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
21,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
21,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
21,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
22,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
22,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
22,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
23,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
25,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
25,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
26,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
26,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
26,4,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
